\"All Kailasians, Ekailasians, volunteers associated with these de facto embassies of Kailasa are to quarantine themselves and adhere to the precautionary measures advised by the local laws,\" the statement from Nithyananda Paramashivam reads

The restrictions come in addition to those previously announced regarding four other countries -- Brazil, Argentina, Chile and South Africa -- that will be implemented starting from Saturday

If the coronavirus vaccine developed by Biological E gets emergency authorisation, it will be the fourth vaccine against coronavirus in India

The restrictions come in addition to those previously announced regarding four other countries -- Brazil, Argentina, Chile and Brazil -- that will be implemented starting from Saturday

India's indigenous COVID-19 vaccine Covaxin is effective against multiple variants, including the double mutant variant of SARS-CoV-2, the Indian Council of Medical Research (ICMR) said on Wednesday. The ICMR said the studies showed that Covaxin also neutralised the UK and Brazil variants of SARS-CoV-2, the coronavirus that causes COVID-19. The double mutant variant is expected to have fuelled the second wave of COVID-19 pandemic in India. Covaxin was developed in collaboration with the ICMR, the National Institute of Virology (NIV) and vaccine manufacturer Bharat Biotech. It was developed using a sample of coronavirus isolated by the NIV. Watch the video for more.Also Read: COVID-19 vaccination: India needs 8 yrs 9 months to achieve herd immunity

Over the past 50 days, 9.78 crore Indians got the first shot of the vaccine, whereas the second dose was administered to a little over 1.5 crore Indians

Union Home Minister Amit Shah also condoled the loss of life in the incident

Congress leader Priyanka Gandhi Vadra said that foreign agencies purchased COVID vaccines from Indian manufacturers much before the Modi government. India placed its first order in January 2021, she added

The new variant, B.1.618 is also called a major immune escape variant, as it can escape immunity even if a person has contracted the virus before and can produce antibodies against it

Of this, 15 states and union territories have only given Covishield, being manufactured by the Pune-based Serum Instiute of India

\"Efficacy against SARS-Cov-2 has been established. COVAXIN has demonstrated an excellent safety record in human clinical trials and in usage under emergency use,\" said Dr Krishna Ella, MD & Chairman, Bharat Biotech

The ICMR has said that the vaccine developed by Bharat Biotech is effective against the UK and Brazil variants of SARS-CoV-2 and the double mutant strain of the virus

Imports of Russia's Sputnik V vaccine are due to arrive soon and the government has also urged Pfizer, Moderna and Johnson and Johnson to sell their products to India

\"We are building a certificate to facilitate travel after these restrictions between the different European countries with testing and vaccination,\" Macron said in an interview that aired Sunday on the CBS News show \"Face the Nation\"

The number of lives lost, as compiled by Johns Hopkins University, is about equal to the population of Kyiv, Ukraine; Caracas, Venezuela; or metropolitan Lisbon, Portugal

Japanese Prime Minister Yoshihide Suga was speaking to reporters at the prime minister's official residence ahead of his trip to the United States for a meeting with President Joe Biden

A waiver would boost vaccine manufacturing and speed up the response to the pandemic in poorer countries which otherwise might have to wait years, they said in a joint letter to Biden sent to news organisations on Wednesday

On a quarterly basis, the impact will be much higher -- a 140 bps loss of nominal GDP in the first quarter, Barclays said in the report

The RBI adopted multiple regulatory forbearance measures and ultra-loose monetary policy to counter economic headwinds. Now it has to work out an exit roadmap

The study published in the British Journal of Sports Medicine said that physical inactivity is linked to more acute symptoms of coronavirus and is the strongest risk factor across all findings